What's Happening?
Milestone Scientific Inc. has launched the first phase of its AI strategy with the introduction of Milo, an AI-enabled digital engagement platform, at the American Society of Pain and Neuroscience (ASPN) Annual Conference. Milo is designed to enhance
customer engagement, support commercial execution, and drive long-term growth. The platform will initially assist with product inquiries, educational information, lead qualification, and connecting healthcare professionals with Milestone's support teams. The company aims to use Milo to provide immediate engagement and improve the customer experience. This initiative is part of Milestone's broader AI strategy, which includes customer engagement, commercial excellence, clinical innovation, and a connected MedTech platform.
Why It's Important?
The launch of Milo represents a significant step in integrating artificial intelligence into healthcare technology, potentially transforming how medical companies engage with customers. By providing immediate responses and facilitating product demonstrations, Milo could improve lead conversion and commercial execution. This development highlights the growing role of AI in enhancing operational efficiency and customer interaction in the medical technology sector. As Milestone continues to develop Milo, the platform could become a cornerstone of a more connected and intelligent medical technology ecosystem, benefiting healthcare professionals and patients alike.
What's Next?
Following the pilot demonstration at ASPN 2026, Milestone plans to gather feedback to guide the future development of Milo and its broader AI initiatives. The company is exploring additional capabilities for Milo, such as interactive product education and AI-assisted virtual demonstrations. As Milestone integrates AI across its operations, the platform could expand to include more advanced features, further enhancing the customer experience and supporting the company's growth in the medical technology market.
